Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Accumulated Expenses (2016 - 2025)

Organogenesis Holdings has reported Accumulated Expenses over the past 10 years, most recently at $49.5 million for Q4 2025.

  • Quarterly results put Accumulated Expenses at $49.5 million for Q4 2025, up 25.55% from a year ago — trailing twelve months through Dec 2025 was $49.5 million (up 25.55% YoY), and the annual figure for FY2025 was $49.5 million, up 25.55%.
  • Accumulated Expenses for Q4 2025 was $49.5 million at Organogenesis Holdings, up from $40.3 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for ORGO hit a ceiling of $49.5 million in Q4 2025 and a floor of $25.4 million in Q1 2021.
  • Median Accumulated Expenses over the past 5 years was $34.6 million (2022), compared with a mean of $34.0 million.
  • Biggest five-year swings in Accumulated Expenses: soared 55.55% in 2021 and later crashed 30.69% in 2025.
  • Organogenesis Holdings' Accumulated Expenses stood at $37.3 million in 2021, then dropped by 29.08% to $26.4 million in 2022, then rose by 13.71% to $30.1 million in 2023, then skyrocketed by 31.19% to $39.5 million in 2024, then rose by 25.55% to $49.5 million in 2025.
  • The last three reported values for Accumulated Expenses were $49.5 million (Q4 2025), $40.3 million (Q3 2025), and $26.3 million (Q2 2025) per Business Quant data.